How to buy Kala Pharmaceuticals stock (KALA)

Kala Pharmaceuticals is a biotechnology business based in the US. Kala Pharmaceuticals shares (KALA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.92 – a decrease of 4.21% over the previous week. Kala Pharmaceuticals employs 43 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Kala Pharmaceuticals stock

Buy Kala Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Kala Pharmaceuticals stock price (NASDAQ: KALA)

Use our graph to track the performance of KALA stocks over time.

Kala Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$5.92
52-week range	$4.21 - $9.25
50-day moving average more info button	$6.38
200-day moving average more info button	$6.52
Wall St. target price	$15.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-11.67

Is it a good time to buy Kala Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kala Pharmaceuticals price performance over time

Historical closes compared with the close of $6 from 2024-12-19

1 week (2024-12-13)	-2.91%
1 month (2024-11-21)	-8.40%
3 months (2024-09-20)	3.63%
6 months (2024-06-21)	11.11%

1 year (2023-12-21)	-13.67%
2 years (2022-12-21)	57.48%
3 years (2021-12-21)	68.5
5 years (2019-12-20)	-97.01%

Kala Pharmaceuticals financials

Gross profit TTM	$1.3 million
Return on assets TTM	-40.25%
Return on equity TTM	-248.11%
Profit margin	0%
Book value	$2.72
Market Capitalization more info button	$26.6 million

TTM: trailing 12 months

Kala Pharmaceuticals share dividends

We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months.

Have Kala Pharmaceuticals's shares ever split?

Kala Pharmaceuticals's shares were split on a 1:50 basis on 20 October 2022 . So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Kala Pharmaceuticals shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Kala Pharmaceuticals shares which in turn could have impacted Kala Pharmaceuticals's share price.

Kala Pharmaceuticals share price volatility

Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $4.21 up to $9.25. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kala Pharmaceuticals's is -2.142. This would suggest that Kala Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Kala Pharmaceuticals has bucked the trend.

Kala Pharmaceuticals overview

KALA BIO, Inc. , a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023.

Frequently asked questions

What percentage of Kala Pharmaceuticals is owned by insiders or institutions?
Currently 5.14% of Kala Pharmaceuticals shares are held by insiders and 48.127% by institutions. How many people work for Kala Pharmaceuticals?
Latest data suggests 43 work at Kala Pharmaceuticals. When does the fiscal year end for Kala Pharmaceuticals?
Kala Pharmaceuticals's fiscal year ends in December. Where is Kala Pharmaceuticals based?
Kala Pharmaceuticals's address is: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476 What is Kala Pharmaceuticals's ISIN number?
Kala Pharmaceuticals's international securities identification number is: US4831191030 What is Kala Pharmaceuticals's CUSIP number?
Kala Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 483119103